ORLANDO

CONFERENCE

November 18, 2023

Sheraton Orlando

Lake Buena Vista Resort

Accreditation Information

Target Audience
Gastroenterologists, hepatologists, internists, family practitioners, surgeons, physician assistants, nurse practitioners, fellows/residents in training, registered nurses, and other healthcare professionals with an interest in GI and liver diseases.

Educational Objectives
After completing this activity, the participant should be better able to:

Describe evolving patient management and treatment strategies for CLD and GI disorders.
Integrate significant advances in therapeutic and diagnostic modalities into clinical practice.
Apply the latest clinical research, including future therapies and their role in the context of the current clinical paradigm.

Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute (TLI). Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.5 ANCC contact hour, which includes 2.0 hours of pharmacology.

Annenberg Center for Health Sciences at Eisenhower has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Disclosure of Relevant Financial Relationships:

All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience all relevant financial relationships related to the content of the presentation or enduring material. Full disclosure of all relevant financial relationships will be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute (TLI), who impacted the content of this activity, have no relevant financial relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all relevant financial relationships that could arise as a result of individuals who control activity content and who have relevant financial relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with relevant financial relationships that can be reconciled with the goals and educational integrity of the CE activity.

Special Requests:

The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.). Please contact us prior to the event at info@galamericas.email.

This activity is supported by educational grants from Aimmune Therapeutics, CymaBay Therapeutics, Inc., Ipsen Biopharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Phathom Pharmaceuticals, Inc, Salix Pharmaceuticals, and Seres Therapeutics.

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower,
the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.